BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 4050495)

  • 1. [Advances in the psychopharmacological management of the narcoleptic patient].
    Salín-Pascual RJ; de la Fuente JR
    Acta Psiquiatr Psicol Am Lat; 1985 Mar; 31(1):62-8. PubMed ID: 4050495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narcolepsy and depression and the neurobiology of gammahydroxybutyrate.
    Mamelak M
    Prog Neurobiol; 2009 Oct; 89(2):193-219. PubMed ID: 19654034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ
    Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of clonidine in narcolepsy.
    Salín-Pascual R; de la Fuente JR; Fernández-Guardiola A
    J Clin Psychiatry; 1985 Dec; 46(12):528-31. PubMed ID: 4066618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narcolepsy--master of disguise: evidence-based recommendations for management.
    Mohsenin V
    Postgrad Med; 2009 May; 121(3):99-104. PubMed ID: 19491546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Narcolepsy: a new perspective on diagnosis and treatment].
    Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current pharmacologic management of narcolepsy.
    Scharf MB; Fletcher KA; Jennings SW
    Am Fam Physician; 1988 Jul; 38(1):143-8. PubMed ID: 3293383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy.
    Scharf MB; Brown D; Woods M; Brown L; Hirschowitz J
    J Clin Psychiatry; 1985 Jun; 46(6):222-5. PubMed ID: 3888969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder.
    Schenck CH; Mahowald MW
    Ann Neurol; 1992 Jul; 32(1):3-10. PubMed ID: 1642469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs for narcolepsy.
    Abad VC; Guilleminault C
    Expert Opin Emerg Drugs; 2004 Nov; 9(2):281-91. PubMed ID: 15571485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal gamma-hydroxybutyrate. Effect on periodic leg movements and sleep organization of narcoleptic patients.
    Bédard MA; Montplaisir J; Godbout R; Lapierre O
    Clin Neuropharmacol; 1989 Feb; 12(1):29-36. PubMed ID: 2713866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium oxybate in narcolepsy with cataplexy: Zurich sleep center experience.
    Poryazova R; Tartarotti S; Khatami R; Baumann CR; Valko P; Kallweit U; Werth E; Bassetti CL
    Eur Neurol; 2011; 65(3):175-82. PubMed ID: 21389728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of narcolepsy.
    Didato G; Nobili L
    Expert Rev Neurother; 2009 Jun; 9(6):897-910. PubMed ID: 19496692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings.
    Mamelak M; Scharf MB; Woods M
    Sleep; 1986; 9(1 Pt 2):285-9. PubMed ID: 3704454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narcolepsy: pathophysiology and pharmacology.
    Nishino S
    J Clin Psychiatry; 2007; 68 Suppl 13():9-15. PubMed ID: 18078360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is narcolepsy a REM sleep disorder? Analysis of sleep abnormalities in narcoleptic Dobermans.
    Nishino S; Riehl J; Hong J; Kwan M; Reid M; Mignot E
    Neurosci Res; 2000 Dec; 38(4):437-46. PubMed ID: 11164570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults.
    Mignot E; Lin L; Finn L; Lopes C; Pluff K; Sundstrom ML; Young T
    Brain; 2006 Jun; 129(Pt 6):1609-23. PubMed ID: 16597649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of mazindol on narcolepsy.
    Iijima S; Sugita Y; Teshima Y; Hishikawa Y
    Sleep; 1986; 9(1 Pt 2):265-8. PubMed ID: 3704452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulpiride, a D2/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy.
    Okura M; Riehl J; Mignot E; Nishino S
    Neuropsychopharmacology; 2000 Nov; 23(5):528-38. PubMed ID: 11027918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narcolepsy and the hypocretins.
    Wurtman RJ
    Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.